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Wound care, tissue viability and maintaining skin integrity represent a large proportion of a 
clinician’s workload encompassing the spectrum of age ranges, from the very young to very old. The 
importance of ensuring that clinical practice is based on the best possible evidence and research is 
accepted by clinical practitioners and academics alike. However, clinical practitioners often find it 
difficult to devote sufficient time to search the literature and develop proposals that will investigate 
issues requiring development, which will enhance the patient experience. As such it is important 
that clinicians are able to access researchers and academics who can assist in developing research 
proposals, undertake service evaluation, assist with audit of current practice, develop new 
technology, advise on best practice and offer education that maintains the clinical knowledge and 
skills required of practitioners.  
 
Of equal importance is the ability of academics and practitioners to work closely with industry to 
develop new interventions, test established products, plan and carry out trials and advise on the 
needs of the clinical areas to ensure that patients receive the most up-to-date evidence- and 
research-based interventions. The importance of this collaborative approach and the formation 
partnerships to promote, develop and implement a quality healthcare service was highlighted by the 
Department of Health
1
.  
 
Skin Interface Sciences Research Group 
The University of Huddersfield has recognised challenges faced by clinicians in undertaking research 
in the specialist area of skin, and in 2011 formed the Skin Interface Sciences (SIS) Research Group. 
The aims of the SIS group are to develop high quality research in the field of skin, undertake research 
programmes that make a difference to clinical practice and drive the improvement of services 
through this evidence-based strategy.  
Modern dressings offer the opportunity for more than simply covering the wound and protecting it 
from the external environment. Technological advances have resulted in dressings that can actively 
target different aspects of the wound healing process in acute, exudating and chronic wounds. 
Hydrocolloids, hydrogels, alginates, polyurethane foam/films and silicone gels can all be used for 
drug delivery to wounds.  The challenging environment means that not all dressings are suitable for 
different wound types and a range of products is required. Incorporated drugs play an active role in 
the wound healing process either directly or indirectly for example, debriding agents for removing 
necrotic tissue or antimicrobials for prevention or treatment of infection. Growth factors can actively 
promote wound healing to aid tissue regeneration by interaction with cells or specific factors within 
the wound environment or even for allogeneic cells, which may provide a specific benefit, with the 
dressing itself acting to maintain a locally moist environment
2
. 
The SIS group is innovative, acknowledging that the management of skin is inter-professional and as 
such, research groups should replicate this. The group comprises academics, researchers and 
clinicians from the Schools of Human and Health Sciences, Computing and Engineering and Applied 
Sciences. Members of the group possess a range of skills and expert knowledge including in the 
fields of: 
• Cell biology 
• Chemistry 
• Engineering 
• Forensic Biology 
• Forensic Science 
• Metrology 
• Microbiology 
• Nursing - with expertise in tissue viability, vascular, wound care and diabetes 
• Pharmacy 
• Podiatry 
• Tribology 
The ethos of the group is to take a multi-disciplinary approach where the skills and expertise of a 
number of scientists, engineers, academics, industrialists and clinicians are brought together in order 
to investigate and contribute to solving real clinical challenges. Evidence of how this multi-
disciplinary approach has led to the development of research in areas related to the integrity of skin 
can be seen in some of the work that has been done in fundamental development areas. Within our 
Pharmacy Research group, we can determine release of antibacterials from dressings, including 
hydrogels, and their delivery into the skin
3
. We also design novel formulations containing 
antimicrobials in combination or which have synergistic effects on antimicrobial efficacy as well as 
enhancing permeation into the skin and microbial niches within the skin that may play a role in 
harbouring bacteria
4
. Composite designs may be required to maintain the effective properties 
optimised for specific wound types while delivering control of the release of active agents. 
 
The EPSRC Centre for Innovative Manufacture in Advanced Metrology with the School of Computing 
and Engineering is focused on development and application of ultra-precision measurement 
techniques. Much of the work is centered on surfaces and how they interact with the environment 
around them. In the context of skin as a surface, the way in which it interacts with the environment 
around it can be indicative of a number of things and influence how the skin will react.  To take the 
example of pressure ulcers, the environment around the skin and how that skin is interacting with 
the support surfaces and other interfaces in close contact can have a huge effect on whether a 
pressure ulcer may develop and the time for progression. By using precise measurement to fully 
understand those conditions and how they influence friction and shear of the skin, a better 
understanding of how to develop tools can be gained. This knowledge can be used to help combat 
the onset of pressure ulcers in a number of ways. Guidance for best practice or engineering of new 
devices in conjunction with our clinical and academic colleagues can be developed in order to 
provide the optimum environment for retention of skin integrity. 
By ensuring multi-disciplinary collaboration and including clinical guidance from the infancy of these 
projects promotes the 'bench to bed' ethos whereby researchers and academics work in partnership 
with clinicians and industry to ensure that the results of research are tangible and are encapsulated 
into the 'real world' of practice. How this works in practice can be seen in the following case study.  
Case Study Exemplifying the Success of Working in Partnership  
The group formed in 2011 and has been successfully working collaboratively with a range of clinical 
and industry partners. One of our clinical partners is Salford Royal NHS Foundation Trust who are 
collaborating with the SIS group to investigate and explore interventions aimed at preventing 
Surgical Site Infection (SSI) in spinal metastatic tumour patients.  
 
Background to the Study 
It is already known that there are a host of risk factors contributing to a higher rate of SSI in patients 
undergoing spinal surgery
5,6
.  The risk of SSI varies between the types of procedure undertaken and 
rises with the increasing number of implants involved.  Co-morbidities such as diabetes also put 
patients at increased risk.  Aside from these more generic contributors which affect the vast majority 
of patients undergoing orthopaedic spinal operations, certain patient groups present additional risk 
factors, putting them in the “high risk” category. 
 
Patients undergoing surgery for secondary (metastatic) tumours of the spine are one such group.  
Spinal metastases are common in cancer patients, and their surgical removal is considered palliative 
treatment to relieve metastatic spinal cord compression (MSCC), which occurs in a significant 
proportion of those with bony spinal disease
7
 .  The surgery aims to stabilise the spine to prevent 
MSCC which, if left untreated, can cause pain, paralysis and incontinence, ultimately leading to 
severely impaired quality of life.  The overwhelming majority of such procedures involve the 
implantation of metalwork across multiple vertebral levels, which immediately puts the patient at 
higher risk over those undergoing more straight-forward spinal procedures (such as discectomy).  
Furthermore, many cancer patients undergo pre-operative chemotherapy and radiotherapy, which 
suppress the immune system thereby impairing the body’s ability to fight off infection
6,8
.  In 
addition, cancer patients often suffer from the ill-effects of malnutrition, which is another potential 
contributing factor
9
.  It is therefore not surprising that for some time, clinicians have realised that 
tumour patients may be more susceptible to developing SSI than those who are not 
immunosuppressed or catabolic.  In particular, it is believed that SSI may develop secondary to poor 
wound healing because of the factors outlined above. 
 
While SSI can be a devastating complication of any type of surgery, leading to increased hospital 
stay, increased morbidity and even death
10
 (without even counting the economic cost to the health 
services), a wound infection for a patient with limited prognosis and initially perceived low quality of 
life could have an even more pronounced negative impact on the wellbeing of them and their family.  
Advances in care over recent decades have facilitated a trend towards repatriating patients for 
nursing care in the community
11
, which is all too important for those who wish to spend as much 
time as possible in their own surroundings and with their loved ones. 
 
The question now is, how can we minimise the likelihood of SSI occurring in the first instance, and 
ultimately expedite improved surgical outcomes and quality of life for our patients?  This question led 
the clinical team at the Spinal Unit at Salford Royal to contact researchers with extensive experience 
in wound care at the University of Huddersfield.  Following an unsuccessful bid for funding to 
investigate one mode of treatment aimed at stimulating wound healing and preventing SSI, the 
group reconvened to assess what could be done to lay the foundations for a high-quality research 
project into preventing SSI in patients with spinal metastases.  It was decided that a systematic 
approach to the problem, involving a multi-disciplinary team was needed.  Frustratingly, while time 
is of the essence in terms of trying to solve the problem of SSI, the group recognised that a well-
structured project providing a solid evidence base to improve the standard of care – potentially over 
a number of years – was necessary to answer the research questions. 
 
• Firstly, we wanted to know whether there were any published reports of interventions 
aimed particularly at reducing SSI in spinal metastatic tumour patients.  This would allow us 
to consider current practice and the adoption of any interventions not already considered 
standard care. 
• Secondly, we needed to find out the rate of SSI in the unit where the research was to be 
carried out – how big was our problem?  From this we would have some baseline data if we 
were to go on to conduct a prospective trial of an intervention we believed would be 
effective at reducing SSI. 
• Thirdly, we wanted to know more about standard care for these patients, in terms of the 
recommended guidelines on SSI – how well were we doing with the Trust’s SSI care bundle 
for this specific patient group, and what could we do to improve care in the short-term? 
• Finally, we needed more information about any potential additional risk factors for SSI in this 
group, which could be the basis for a prospective study. 
 
These four components formed our bid to Foundation Urgo in 2011.  After our initial application for 
funding and invitation to discuss the project in more detail, the group was awarded £19,000 to cover 
the costs associated with undertaking the project.  Beginning in November 2011, the academic and 
clinical groups worked closely to initiate a systematic review assessing which interventions aimed at 
preventing SSI specifically in spinal metastatic tumour patients had already been reported (an 
abstract for which won first place in the “Hard-to-Heal” category at the Wounds UK conference in 
November 2012).  Alongside this, a successful application to obtain ethical approval for a 
retrospective study was submitted through the NHS Research Ethics Service proportionate review 
system.  This study will yield important baseline data characterising the patient group, enabling us to 
find out the rate of SSI, the compliance with the SSI care bundle and how this can be improved 
through raising awareness internally of the importance of SSI in this patient group. As an additional 
benefit, this project has already brought forward a roll-out of the surveillance of spinal wounds by 
the SSI surveillance team at Salford Royal, something which has been an aim of the department for 
some time.  This is thanks to the commitment of senior management to this important area, and in 
particular to this project. 
 
As of November 2012, data collection and analysis is still underway, with expectation that the full 
data set will be ready for publication in the spring of 2013.  Following on from the analysis, the team 
will produce a patient information leaflet describing the steps the Trust and the patient can take to 
minimise the risk of infection.  Additionally, the team will work closely with the Infection Control 
department at Salford Royal to develop up-to-date guidelines for clinicians dealing with these 
patients.  A re-audit one year after introduction of the leaflet and guideline will enable the team to 
assess whether these have been beneficial.  Furthermore, the identification of any potential risk 
factors will be investigated further to assess whether there is scope for conducting a prospective 
interventional clinical trial. 
 
The project being undertaken by the University of Huddersfield and Salford Royal has its roots 
embedded in two core principles: 1) the improvement in the standard of patient care through 2) a 
collaborative approach between the Higher Education and Health Service sectors.  It is the aim of the 
SIS Research Group that future challenges in wound care will be tackled by further such 
collaboration. 
Conclusion 
The development of the SIS group has highlighted the significance of a multi-disciplinary approach to 
skin integrity issues and the importance of academia and clinical practice working in partnership to 
augment and develop research that enhances patient care.  Time pressures on clinical staff can be 
alleviated somewhat by this collaborative approach, and the presence of full-time research staff 
employed within the healthcare sector can be a great advantage.  Researchers embedded within the 
NHS increase the capacity to push forward innovative projects by providing a link between the 
clinical and academic groups. 
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